The tumor suppressor and transcriptional factor p53 is a phosphorylated protein. There are multiple potential phosphorylation sites on the amino- and carboxyl-terminal regions of p53, but the role of phosphorylation at each site in the regulation of the functions of p53 is not well understood. The functions of p53 include transcriptional activation of genes involved in cell cycle arrest (WAF1/Cip1) and apoptosis (Bax anf Fas/APO-1). The preliminary studies showed that radiation exposure caused the wild-type p53-containing leukemia cell line BV173 to apoptosis rapidly and that treatment with arabinosyl cytosine (ara-C) caused a relatively slow apoptosis. Analyses of gene expression in the treated cells revealed that radiation activated both Bax and Fas/AP0-1 expression, whereas ara-C activated Bax but not Fas/APO-1 expression. Two-dimensional gel electrophoresis of immunoprecipitated, 35S-methionine-labeled p53 and the treated cells showed that p53 existed as different isoforms with distinct isoelectric points in radiated and ara-C-treated cells. The previous study characterized 143Ala as a temperature-sensitive (ts) mutant that activates endogenous WAF1/Cip1 and Fas/APO-1 genes at permissive temperatures. Two-dimensional gel analyses indicated that 143 Ala has diffferent isoelectric points at permissive and non-permissive temperatures, whereas the isoelectric points of the non-temperature-sensitive mutant 248Trp did not change with temperature switch. Phosphorylation is a key form of posttranslational modification that alters the isoelectric points of proteins. Therefore, these results strongly suggest that phosphorylation may play an important role in regulating the transcriptional activation functions of p53 in response to radiation and ara-C and in conferring the functional switch in the 143Ala ts mutant. The investigators hypothesize that differential phosphorylation of p53 accounts for its different transcriptional activities in irradiated and ara-C-treated BV173 cells. In this study they hope to identify important phosphorylation sites on p53 and shed light on the role of phosphorylation in the regulation of the p53 functions.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
First Independent Research Support & Transition (FIRST) Awards (R29)
Project #
5R29CA067987-03
Application #
2769801
Study Section
Pathology B Study Section (PTHB)
Program Officer
Gallahan, Daniel L
Project Start
1996-09-01
Project End
2001-08-31
Budget Start
1998-09-01
Budget End
1999-08-31
Support Year
3
Fiscal Year
1998
Total Cost
Indirect Cost
Name
University of Texas MD Anderson Cancer Center
Department
Neurology
Type
Other Domestic Higher Education
DUNS #
001910777
City
Houston
State
TX
Country
United States
Zip Code
77030
Jabbur, James R; Tabor, Amy D; Cheng, Xiaodong et al. (2002) Mdm-2 binding and TAF(II)31 recruitment is regulated by hydrogen bond disruption between the p53 residues Thr18 and Asp21. Oncogene 21:7100-13
Jabbur, James R; Zhang, Wei (2002) p53 Antiproliferative function is enhanced by aspartate substitution at threonine 18 and serine 20. Cancer Biol Ther 1:277-83
Jabbur, J R; Huang, P; Zhang, W (2001) Enhancement of the antiproliferative function of p53 by phosphorylation at serine 20: an inference from site-directed mutagenesis studies. Int J Mol Med 7:163-8
Jabbur, J R; Huang, P; Zhang, W (2000) DNA damage-induced phosphorylation of p53 at serine 20 correlates with p21 and Mdm-2 induction in vivo. Oncogene 19:6203-8
Rhee, C H; Hess, K; Jabbur, J et al. (1999) cDNA expression array reveals heterogeneous gene expression profiles in three glioblastoma cell lines. Oncogene 18:2711-7
Ruan, S; Okcu, M F; Pong, R C et al. (1999) Attenuation of WAF1/Cip1 expression by an antisense adenovirus expression vector sensitizes glioblastoma cells to apoptosis induced by chemotherapeutic agents 1,3-bis(2-chloroethyl)-1-nitrosourea and cisplatin. Clin Cancer Res 5:197-202
Fuller, G N; Rhee, C H; Hess, K R et al. (1999) Reactivation of insulin-like growth factor binding protein 2 expression in glioblastoma multiforme: a revelation by parallel gene expression profiling. Cancer Res 59:4228-32
Rhee, C H; Ruan, S; Chen, S et al. (1999) Characterization of cellular pathways involved in glioblastoma response to the chemotherapeutic agent 1, 3-bis(2-chloroethyl)-1-nitrosourea (BCNU) by gene expression profiling. Oncol Rep 6:393-401
Ruan, S; Okcu, M F; Ren, J P et al. (1998) Overexpressed WAF1/Cip1 renders glioblastoma cells resistant to chemotherapy agents 1,3-bis(2-chloroethyl)-1-nitrosourea and cisplatin. Cancer Res 58:1538-43
Kobayashi, T; Ruan, S; Jabbur, J R et al. (1998) Differential p53 phosphorylation and activation of apoptosis-promoting genes Bax and Fas/APO-1 by irradiation and ara-C treatment. Cell Death Differ 5:584-91